[EN] HDAC3 CATALYTIC INHIBITOR DEVELOPMENT AND USES THEREOF<br/>[FR] DÉVELOPPEMENT D'INHIBITEURS CATALYTIQUES DE HDAC3 ET LEURS UTILISATIONS
申请人:DANA FARBER CANCER INST INC
公开号:WO2020252323A1
公开(公告)日:2020-12-17
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC3 activity.